Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber, will highlight its portfolio of thermoplastic elastomers (TPEs) at the Healthcare Elastomer Conference from May 21-22 in Schaumburg, Illinois. The conference is sponsored by Rubber & Plastics News, broadly focusing on TPEs and the best ways to incorporate them into application designs.
In the medical devices market, soft-touch materials and overlays are often needed along with hard plastics. Recent trends in the industry, such as home healthcare, self-administered care, and an aging population, require medical devices and equipment that are patient and service provider friendly.
Trinseo offers two styrenic block copolymers (TPSs) to meet this marketplace need under the brands MEGOL™ TPS-SEBS Compounds and RAPLAN™ TPS-SBC Compounds. Materials range from highly elastomeric and opaque to semi-rigid and transparent and can be used for injection molding, extrusion, or soft-touch overlays. MEGOL™ and RAPLAN™ materials are available with a full battery of ISO 10993 biocompatibility tests (MED). MEGOL™ materials are also available with limited biocompatibility testing for skin contact (SK) applications.
Trinseo added TPEs to complement its portfolio of rigid plastics in 2017 when it acquired API, a manufacturer of thermoplastic elastomeric compounds and bioplastics. As a result, Trinseo is able to offer customers the convenience of obtaining both their rigid and soft-touch plastics from one source and the advantage of a single point of contact for overmolding solutions.
Trinseo supports medical device customers with material solutions for Single and Multiple Use Devices, Equipment Housings, Drug Delivery Systems, and Medical Wearables. In addition to TPEs, Trinseo is known globally for its rigid plastics brands including CALIBRE™ and CALIBRE™ MEGARAD™ Polycarbonate Resins, EMERGE™ Advance Resins, and MAGNUM™ ABS Resins. Trinseo adheres to current Good Manufacturing Practices (cGMP) and holds an ISO 13485 certification.
Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day — products that are intrinsic to how we live our lives — across a wide range of end-markets, including automotive, consumer electronics, appliances, medical devices, lighting, electrical, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.8 billion in net sales in 2019, with 17 manufacturing sites around the world, and approximately 2,700 employees. For more information visit www.trinseo.com.
This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release may include, without limitation, forecasts of growth, revenues, business activity, acquisitions, financings and other matters that involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. As a result of the foregoing considerations, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.